(旧版)科学的根拠に基づく糖尿病診療ガイドライン 改訂第2版

 
18.糖尿病における急性代謝失調


文献

1) Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Arch Intern Med. 2004;164(17):1925-31. レベル4
2) Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004;27(8):1873-8. レベル2
3) Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, E Kitabchi A. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117(5):291-6. レベル2
4) Della Manna T, Steinmetz L, Campos PR, Farhat SC, Schvartsman C, Kuperman H, Setian N, Damiani D. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005;28(8):1856-61. レベル2
5) Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden DR, Trimble ER, Bell PM. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care. 1997;20(9):1347-52. レベル2
6) Gamba G, Oseguera J, Castrejón M, Gómez-Pérez FJ. Bicarbonate therapy in severe diabetic ketoacidosis. A double blind, randomized, placebo controlled trial. Rev Invest Clin. 1991;43(3):234-8. レベル2
7) Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986;105(6):836-40. レベル2
8) Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 1983;57(1):177-80. レベル2
9) MacIsaac RJ, Lee LY, McNeil KJ, Tsalamandris C, Jerums G. Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies. Intern Med J. 2002;32(8):379-85. レベル4
10) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-86. レベル1
11) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53. レベル1
12) Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103-17. レベル2
13) Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care. 1995;18(5):625-30. レベル4
14) 鮴谷佳和,松本正幸,土屋 博,高崎幹裕,滝沢 哲,奥谷幸彦,今村早生,宗平純一,林 淳史,松下 元,槻尾義昭.高齢糖尿病患者における痴呆発症 血糖コントロールとの関係.糖尿病.1995;38(4):267-73. レベル4
15) Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes. 1991;40(2):223-6. レベル6
16) 香野修介,今村洋一,小路眞護,林 秀樹,山田研太郎,野中共平.糖尿病患者における低血糖閾値変動に関する検討.糖尿病.1998;41(12):1089-94. レベル4
17) Levy CJ, Kinsley BT, Bajaj M, Simonson DC. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM. Diabetes Care. 1998;21(8):1330-8. レベル4
18) Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;333(26):1726-31. レベル4
19) Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet. 1994;344(8918):283-7. レベル5
20) Anderson JH, Brunelle RL, Koivisto VA, Pfuetzner A, Trautmann ME, Vignati L, DiMarchi R, Multicenter Insulin Lispro Study Group. インスリン投与によるインスリン依存型糖尿病患者における食後過血糖の抑制および低血糖頻度の低下.臨床医薬.2000;16:1687-96. レベル1
21) Anderson JH, Brunelle RL, Keohane P, Koivisto VA, Trautmann ME, Vignati L, DiMarchi R. インスリン非依存糖尿病におけるインスリンアナログの食事時療法による食後過血糖と低血糖発現の改善.臨床医薬.2000;16:1697-707. レベル1
22) Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28(4):950-5. レベル1
23) Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med. 1996;124(4):379-88. レベル1


【参考としたレビュー,ガイドライン】
a) Trachtenbarg DE. Diabetic ketoacidosis. Am Fam Physician. 2005;71(9):1705-14.
b) Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM; American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care. 2004;27 Suppl 1:S94-102.
c) Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24(1):131-53.
d) Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Physician. 2005;71(9):1723-30. 
e) 野中共平.無自覚性低血糖.Diabetes Journal:糖尿病と代謝.1995;23(2):48-55.
f) Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902-12. 
g) Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54(12):3592-601.
h) Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005;28(5):1245-9.


 
ページトップへ

ガイドライン解説

close-ico
カテゴリで探す
五十音で探す

診療ガイドライン検索

close-ico
カテゴリで探す
五十音で探す